Antibody depletion and cytotoxic drug therapy in severe systemic lupus erythematosus

Klippel, 1990, Survival in SLE, 187 Reveille, 1990, Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death, Arthritis Rheum, 33, 37, 10.1002/art.1780330105 Austin, 1986, Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs, N Engl J Med, 314, 614, 10.1056/NEJM198603063141004 Klippel, 1990, Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease, J Am Med Assoc, 263, 1812, 10.1001/jama.1990.03440130100033 Baker, 1987, Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. A long-term case-control follow-up study, Am J Med, 83, 1, 10.1016/0002-9343(87)90490-6 Cupps, 1990, Cyclophosphamide: To pulse or not to puls, Am J Med, 89, 399, 10.1016/0002-9343(90)90366-L Fox, 1989, Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus, 20 Hill, 1964, Cytotoxic drugs for systemic lupus (letter), Br Med J, 1, 370, 10.1136/bmj.1.5379.370 Barrat, 1970, Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood, Lancet, 2, 479, 10.1016/S0140-6736(70)90108-X Steinberg, 1971, Cyclophosphamide in lupus nephritis: a controlled trial, Ann Intern Med, 75, 165, 10.7326/0003-4819-75-2-165 Felson, 1984, Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis: results of a pooled analysis, N Engl J Med, 311, 1528, 10.1056/NEJM198412133112402 Perez, 1989, Cyclophosphamide use in a young woman with antibodies and recurrent cerebrovascular accident, South Med J, 82, 1421, 10.1097/00007611-198911000-00021 Dinant, 1982, Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis, Ann Intern Med, 96, 728, 10.7326/0003-4819-96-6-728 Balow, 1987, Lupus nephritis, 106, 79 Gibbons, 1988, Acute non-lymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide in the treatment of lupus nephritis, Arthritis Rheum, 31, 1552, 10.1002/art.1780311212 Kattwinkel, 1991, Overwhelming fatal infection in a young woman after intravenous cyclophosphamide therapy for lupus nephritis, J Rheumatol, 18, 79 LaRochelle, 1985, Iv cyclophosphamide therapy of steroid resistant neuropsychiatric SLE, Clin Exp Rheumatol, 3, 159 Boumpas, 1990, Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus, Ann Intern Med, 112, 674, 10.7326/0003-4819-112-9-674 El Mouzan, 1988, Myelofibrosis and pancytopenia in systemic lupus erythematosus, Acta Haematol, 80, 219, 10.1159/000205641 Schroeder, 1987, Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus, Ann Intern Med, 107, 344, 10.7326/0003-4819-107-2-344 Dennis, 1986, Corticosteroidinduced suppression of murine B cell immune response antigens, J Immunol, 136, 1600 McMillan, 1976, The effect of corticosteroids on human IgG synthesis, J Immunol, 116, 1592 Saxon, 1977, Glucocorticosteroids in vivo inhibit human suppressor cell function and diminish B lymphocyte responsiveness in in-vitro immunoglobulin synthesis, J Clin Invest, 61, 922, 10.1172/JCI109017 Smith, 1977, Glucocorticol receptors and glucocorticoid sensitivity of mitogen stimulated and unstimulated human lymphocytes, Nature, 267, 523, 10.1038/267523a0 Cupps, 1984, Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids, J Immunol, 132, 170 Dukor, 1970, Prevention of cyclophosphamide-induced tolerance to erythrocytes by pretreatment with cortisone, 133, 280 Hedon, 1902, Sur l'hemolyse par les glycosides, globulicides et les conditions de milieu qui la favorisent ou l'émpechent, Arch Internist Pharmacol Gand Paris, 7, 381 Jones, 1976, Plasmapheresis in the management of acute systemic lupus erythematosus, Lancet, 1, 709, 10.1016/S0140-6736(76)93088-9 Lockwood, 1975, Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis, Br Med J, 2, 252, 10.1136/bmj.2.5965.252 Jones, 1979, Evidence for therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus, Q J Med, 48, 555 Jones, 1981, Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA, Arthritis Rheum, 24, 1113, 10.1002/art.1780240901 Jones, 1982, Plasmapheresis in SLE, Clin Rheum Dis, 8, 243, 10.1016/S0307-742X(21)00211-3 Schlansky, 1981, Plasmapheresis in systemiclupus erythematosus. A cautionary note, Arthritis Rheum, 24, 49, 10.1002/art.1780240108 Kater, 1981, Effect of plasmapheresis in active systemic lupus erythematosus, Neth J Med, 24, 209 Leaker, 1986, Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression, Clin Nephrol, 25, 236 Clark, 1981, Chronic plasma exchange therapy in SLE nephritis, Clin Nephrol, 16, 20 Wei, 1983, Randomised trial of plasma exchange in mild systemic lupus erythematosus, Lancet, 1, 17, 10.1016/S0140-6736(83)91561-1 1985, A randomized trial of plasma exchange in severe acute systemic lupus erythematosus, Plasma Ther Transfus Technol, 6, 535 Belghiti-Deprez, 1988, A controlled trial of plasma exchange in severe acute systemic lupus erythematosus Levey, 1990, Progression and remission in the Lupus Nephritis Collaborative Study (LNCS), J Am Soc Nephrol, 1, 310 Derksen, 1988, Prospective multicentre trial on the short-term effects of plasma versus cytotoxic drugs in steroid-resistant lupus nephritis, Neth J Med, 33, 168 Wallace, 1987, Controlled study of the use of plasmapheresis in steroid/immunosuppressive resistant systemic lupus erythematosus with nephrotic syndrome, 91 Guillaume, 1988, Controlled study of plasma exchange in pemphigus, Arch Dermatol, 124, 1659, 10.1001/archderm.1988.01670110019004 Sutton, 1989, Complications of plasma exchange, Transfusion, 29, 124, 10.1046/j.1537-2995.1989.29289146829.x Bystryn, 1988, Plasma exchange in pemphigus, Arch Dermatol, 124, 1702, 10.1001/archderm.1988.01670110062013 Bystryn, 1970, Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion, J Exp Med, 132, 1279, 10.1084/jem.132.6.1279 Bystryn, 1971, A model for regulation of antibody by serum antibody, 627 Uhr, 1968, Regulatory effect of antibody on the immune response, Adv Immunol, 8, 81, 10.1016/S0065-2776(08)60465-4 Kramer, 1982, Mechanisms for redistribution of plasmaproteins following acute protein depletion, Am J Physiol, 243, 803 Charlton, 1985, Analysis of immunoglobulin G kinetic in the non-steady-state, J Lab Clin Med, 105, 312 Kellogg, 1988, Kinetics modelling of plasma exchange, J Clin Apheresis, 4, 183, 10.1002/jca.2920040409 Lockwood, 1979, Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange, N Engl J Med, 300, 524, 10.1056/NEJM197903083001003 Derksen, 1984, Rebound and overshoot after plasma exchange in humans, J Lab Clin Med, 104, 35 Terman, 1978, Specific suppression of antibody rebound after extracorporal immunoadsorption. I. Comparison of single versus combination chemotherapeutic agents, Clin Exp Immunol, 34, 32 Euler, 1985, Membrane plasmapheresis technique in rats. Confirmation of antibody rebound, J Immunol Methods, 84, 313, 10.1016/0022-1759(85)90438-7 Euler, 1987, The antibody rebound as a rationale for synchronizing plasmapheresis with pulse cytotoxic drug, 200 Graf, 1969, Regulation of antibody formation by serum antibody. I. Removal of specific antibody by means of immunoadsorption, J Exp Med, 130, 1175, 10.1084/jem.130.5.1175 Uhr, 1961, Antibody formation: the suppression of antibody formation by passively administered antibodies, J Exp Med, 113, 935, 10.1084/jem.113.5.935 Chang, 1969, Studies on the mechanism of the suppression of active antibody synthesis by passively administered antibody, J Immunol, 102, 37 Cerottini, 1969, The immunosuppressive effect of passively administered antibody Ig-fragments, J Immunol, 102, 1008 Pierce, 1969, Immune responses in vitro. II. Suppression of the immune response in vitro by specific antibody, J Exp Med, 130, 365, 10.1084/jem.130.2.365 Wigzell, 1966, Antibody synthesis at the cellular level: antibody induced suppression of 7s-antibody synthesis, J Exp Med, 124, 953, 10.1084/jem.124.5.953 Brody, 1967, Studies on the control of antibody synthesis. Interaction of antigen competition and suppression of antibody formation by passive antibody on the immune response, J Exp Med, 126, 81, 10.1084/jem.126.1.81 Vendeville, 1988, Plasma exchange in a rat model of autoimmune glomerulonephritis, Nephrol Dial Transplant, 3, 405, 10.1093/oxfordjournals.ndt.a091688 Reding, 1988, Plasma exchange technique in the unheparinized, unanaesthetized rat, Lab Anim, 22, 293, 10.1258/002367788780746160 Reding, 1987, Successful removal of immune and preformed xeno-antibodies by plasma exchange in rats, Em Surg Res, 19, 74 Charlton, 1988, A comparison of the effects of plasma exchange and immunoadsorption on anti-insulin antibodies in rabbits, Clin Exp Immunol, 72, 326 Sturgill, 1970, Stimulation of proliferation of 19S antibody forming cells in the spleens of immunized guinea-pigs after exchange transfusion, Nature, 228, 1304, 10.1038/2281304a0 Branda, 1975, Plasma exchange in the treatment of immune disease, Transfusion, 15, 570, 10.1046/j.1537-2995.1975.15676082232.x Minchin, 1990, Polyclonal activation of rat B cells, II. Dextran Sulfate as a cofactor in mitogen-induced and antigen-induced differentiation of rat B lymphocytes, J Immunol, 145, 2427 Nasca, 1990, Antibody response to pneumococcal polysaccharide vaccine in myasthenia gravis: effect of therapeutic plasmapheresis, J Clin Apheresis, 5, 133, 10.1002/jca.2920050304 Tew, 1980, The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigenbinding dendritic cells as accessory cells, Immunol Rev, 53, 175, 10.1111/j.1600-065X.1980.tb01044.x Stockinger, 1978, Fc receptor dependency of antibody mediated feedback regulation: on the mechanism of inhibition, Cell Immunol, 40, 395, 10.1016/0008-8749(78)90347-7 Caulfield, 1987, Immunoregulation by antigen/antibody complexes. I. Specific immunosuppression induced in vivo with immune complexes formed in antibody excess, J Immunol, 138, 3680 Rossi, 1989, Antiidiotypes against autoantibodies in pooled normal polyspecific IgG, J Immunol, 143, 4104 Corvetta, 1989, Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus: report of three cases, Clin Exp Rheumatol, 7, 295 Smolens, 1957, Human plasmapheresis and its effect on antibodies, J Immunol, 79, 434 Krapf, 1985, The estimation of circulating immune complexes, C3d, and antids-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report, Clin Exp Rheumatol, 3, 159 Barclay, 1980, Adverse effects on plasma exchange on anti-D production in rhesus immunisation owing to removal of inhibitory factors, Br Med J, 280, 1569, 10.1136/bmj.280.6231.1569 Isbister, 1977, Development of Rh-specific maternal autoantibodies following intensive plasmapheresis Rh immunisation during pregnancy, Vox Sang, 33, 353, 10.1111/j.1423-0410.1977.tb02256.x Marner, 1985, Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis, Diabetes Res, 2, 231 Van Wanghe, 1982, Effect of intravenous cyclophosphamide as an adjuvant to therapeutic plasma exchange in rheumatoid arthritis, Plasma Ther Transfus Technol, 3, 171 Roujeau, 1983, Effects of various immunosuppressive regimes on the “rebound phenomenon” induced by plasma exchange in pemphigus, 285 Council on Scientific Affairs, 1985, Current status of plasmapheresis and related techniques, J Am Med Assoc, 253, 819, 10.1001/jama.1985.03350300107030 Shumak, 1984, Therapeutic plasma exchange, N Engl J Med, 310, 762, 10.1056/NEJM198403223101206 Lin, 1973, Differential lethal effect of cytotoxic agents on proliferating and nonproliferating lymphoid cells, Cancer Res, 33, 1716 Kakiuchi, 1990, Differential sensitivity of specific and nonspecific antigenpresentation by B cells to a protein synthesis inhibitor, J Immunol, 145, 1653 Turk, 1972, Selective depletion of lymphoid tissue by cyclophosphamide, Clin Exp Immunol, 10, 285 Dau, 1977, Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis, N Engl J Med, 297, 1134, 10.1056/NEJM197711242972102 Aisenberg, 1967, Studies on cyclophosphamide-induced tolerance to sheep erythrocytes, J Exp Med, 125, 833, 10.1084/jem.125.5.833 Stevenson, 1979, Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B cell activation, Immunology, 39, 391 Gagnon, 1981, The effect of chronic daily cyclophosphamide administration on established antibody responses, Clin Exp Immunol, 46, 178 Herrlinger, 1978, Different suppressive effects of combined cyclophosphamide-antigen treatment compared with exclusive cyclophosphamide treatment of primary and secondary humoral immune reactivity, Int Arch Allergy Appl Immunol, 57, 82, 10.1159/000232087 Mayumi, 1990, Cyclophosphamide-inducedchimera-type tolerance to allografts: an overview of drug-induced immunological tolerance, Fukuoka Acta Med, 81, 20 Nilsson, 1988, Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII, N Engl J Med, 318, 947, 10.1056/NEJM198804143181503 Eto, 1991, Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice, J Immunol, 146, 1402 Fauchald, 1987, Plasma exchange and immunosuppressive therapy before renal transplantation, 19, 727 Grailer, 1991, Donor-specific cytotoxic T lymphocyte hyporesponsiveness following renal transplantation in patient pretreated with donor-specific transfusions, Transplantation, 51, 320, 10.1097/00007890-199102000-00009 Euler, 1987, Synchronization of plasmapheresis and pulse cyclophosphamide in pemphigus vulgaris, Arch Dermatol, 123, 1205, 10.1001/archderm.1987.01660330116023 Dau, 1980, Plasmapheresis therapy in myasthenia gravis, Muscle Nerv, 3, 468, 10.1002/mus.880030603 Euler, 1982, Effect of early plasmapheresis and high-dose cyclophosphamide therapy in Goodpasture's syndrome, 238 Ruocco, 1984, Plasmapheresis as an alternative or adjunctive therapy in problem cases of pemphigus, Dermatologica, 168, 219, 10.1159/000249707 Barr, 1987, Persistently active lupus erythematosus treated with intermittent plasmapheresis and bolus cyclophosphamide, 79 Zielinski, 1988, Plasmapheresis in the treatment of systemic lupus erythematosus: a controlled study, Acta Med Austriaca, 15, 155 Huston, 1988, A controlled trial of pulse cyclophosphamide and plasmapheresis therapy of lupus nephritis, Arthritis Rheum, 31, 55S Heijnen, 1986, Effect of alpha-endorphin on the antigen-induced primary antibody response of human blood B cells in vitro, J Immunol, 136, 213 Macey, 1990, CD4 And CD8 subpopulation changes during high dose intravenous immunoglobulin treatment, Br J Haematol, 76, 513, 10.1111/j.1365-2141.1990.tb07909.x Schroeder, 1989, Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus, 203 Clark, 1991, Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: Design of the LPSG trial, J Clin Apheresis, 6, 40, 10.1002/jca.2920060109 Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101 Liang, 1989, Reliability and validity of six systems for the clinical assessment of disease activity in lupus erythematosus, Arthritis Rheum, 32, 1107, 10.1002/anr.1780320909 Urowitz, 1984, The lupus activity criteria count, J Rheumatol, 11, 783 Hughes, 1990, Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever, J Infect Dis, 161, 381, 10.1093/infdis/161.3.381 Dau, 1990, Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease, J Neuroimmunol, 30, 15, 10.1016/0165-5728(90)90048-R Dau, 1991, Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus, J Rheumatol, 18, 270 Udea, 1989, Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus, J Immunol, 143, 3988 Golbus, 1988, Increased immunoglobulin response to gamma-interferon by cultured lymphocytes from subjects with systemic lupus erythematosus, Clin Immunol Immunopathol, 46, 129, 10.1016/0090-1229(88)90013-X Rifle, 1990, Synchronization of plasma exchange and pulse cyclophosphamide in Grave's ophthalmopathy, World Apheresis Assoc, 3, 127 Euler, 1987, A concept of synchronizing plasmapheresis with pulse immunosuppression: Application in rapidly progressive glomerulonephritis, 33 Euler, 1991, Intensivierte Initialtherapie der schweren Wegener'schen Granulomatose, Nieren Hochdruckkrkh, 20, 222 Schroeder, 1987, Synchronization of plasmapheresis and pulse cyclophosphamide in refractory in rheumatoid arthritis, 689 Charlton, 1982, Selective adsorption of IgG and IgM: evaluation of systems for plasma exchange, Artif Organs, 28, 400 Schneider, 1990, Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus, J Rheumatol, 17, 900 Nilsson, 1981, A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia, Blood, 51, 38, 10.1182/blood.V58.1.38.38 Yount, 1988, Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B and IgG rheumatoid factor, Monogr Allergy, 23, 41 Harata, 1991, Selective adsorption of anti-DNA antibodies and their idiotype-positive cells in vitro using an anti-idiotypic antibody-affinity column: possible application to plasma exchange, J Clin Apheresis, 6, 34, 10.1002/jca.2920060108 Lockwood, 1987, Specific immunoadsorption, 129, 234 Zeuner, 1992, Effect of antigen-specific immunoadsorption on antibody kinetics in a rat model, Biomater Artif Cells Artif Organs Ryan, 1986, Repeated membrane plasma separation with online sorbent treatment in the conscious rat, Artif Organs, 10, 135, 10.1111/j.1525-1594.1986.tb02532.x Nilsson, 1990, Extracorporeal immunoadsorption therapy on rats. In vivo depletion of specific antibodies, Clin Exp Immunol, 82, 440, 10.1111/j.1365-2249.1990.tb05468.x Kelsoe, 1979, Reciprocal expansions of idiotypic and antiidiotypic clones following antigen stimulation, Nature, 278, 333, 10.1038/279333a0 Müller-Ruchholtz, 1974, The influence of cyclophosphamide and other homologue oxazaphosphorine-2-oxides on transplantation-immunologic reactions, Drug Res, 24, 1160